GP Circular 008-26 Levemir Discontinuation

GP Circular 008-26 on Levemir discontinuation informs GPs that Novo Nordisk is discontinuing all Levemir® (insulin detemir) products by end of 2026 and that clinicians must plan to switch affected patients to alternative basal insulins with appropriate guidance and monitoring.